Document is current
Any future updates will be listed below
-
Authors
Rivera, Daniel
Bouras, Alexandros
Mattioli, Milena
Anastasiadou, Maria
Pacentra, Anna Chiara
Pelcher, Olivia
Koziel, Corrine
Schupper, Alexander J.
Chanenchuk, Tori
Carlton, Hayden
Ivkov, Robert
Hadjipanayis, Constantinos G.
-
Funding
Funding for this research was provided by:
National Cancer Institute (5R01 CA247290, 5R01 CA247290, 5R01 CA247290, 5R01 CA247290, 5R01 CA247290, 5R01 CA247290, 5R01 CA247290, 5R01 CA247290, 5R01 CA247290, 1R01 CA257557, 1R01 CA257557, 5R01 CA247290)
- License Information
-
More Information
Article History
Received: 21 November 2024
Accepted: 21 March 2025
First Online: 27 March 2025
Declarations
:
: C.H. is a paid consultant for Hemerion Therapeutics, Integra, Stryker Corp., Synaptive Medical, and True Digital Surgery, which have no relationship with the work presented in the manuscript. R.I. was a consultant and member of the Scientific Advisory Board of Imagion Biosystems, Ltd. through end of Dec 2023. This arrangement was reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. R.I. is an inventor listed on several nanoparticle patents. All patents are assigned to either The Johns Hopkins University or Aduro Biosciences, Inc. All other authors report no other conflicts of interest.
